DiaSpect Medical Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $28.5M
Latest Deal Amount

DiaSpect Medical General Information


Developer of in vitro diagnostic systems designed to offer cost effective methods for instant hemoglobin related measurements. The company's systems offer hemoglobin measurements to primary care anywhere in the world, as well as provide fast hemoglobin related information in special clinics, enabling clients to improve patient care and offer improved outcomes.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Von-Cancrin-Str. 3
  • 63877 Sailauf
  • Germany
+49 06099 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DiaSpect Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 21-Mar-2014 $28.5M 000.00 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Early Stage VC 01-Jun-2008 Completed Startup
To view DiaSpect Medical’s complete valuation and funding history, request access »

DiaSpect Medical Executive Team (4)

Name Title Board Seat Contact Info
Ralf Gütlein Director, Research & Development & Board Member
You’re viewing 1 of 4 executive team members. Get the full list »

DiaSpect Medical Board Members (3)

Name Representing Role Since
Ralf Gütlein DiaSpect Medical Director, Research & Development & Board Member 000 0000
You’re viewing 1 of 3 board members. Get the full list »

DiaSpect Medical Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Allba Invest Venture Capital Minority 000 0000 000000 0
To view DiaSpect Medical’s complete investors history, request access »